InvestorsHub Logo

Investor2014

09/20/17 12:26 PM

#120901 RE: sokol #120896

Yes there lies the answer. Publicly touting homoeostasis, dose dependent positive cognitive response etc., while knowing that in actual fact the results are quite the opposite would expose the company to class action lawsuits and SEC action.

powerwalker

09/20/17 2:50 PM

#120921 RE: sokol #120896

Plus, sokol, there would be resignations from the BOD and SAB if any member thought that Dr. M was not being a straight shooter on these matters.